ATE169226T1 - Verwendung von aus blutplättchen gewonnenem wachstumsfaktor zur herstellung eines medikaments zur behandlung von gastrointestinaler geschwüre - Google Patents
Verwendung von aus blutplättchen gewonnenem wachstumsfaktor zur herstellung eines medikaments zur behandlung von gastrointestinaler geschwüreInfo
- Publication number
- ATE169226T1 ATE169226T1 AT92917382T AT92917382T ATE169226T1 AT E169226 T1 ATE169226 T1 AT E169226T1 AT 92917382 T AT92917382 T AT 92917382T AT 92917382 T AT92917382 T AT 92917382T AT E169226 T1 ATE169226 T1 AT E169226T1
- Authority
- AT
- Austria
- Prior art keywords
- growth factor
- derived growth
- platele
- medication
- producing
- Prior art date
Links
- 208000025865 Ulcer Diseases 0.000 title abstract 2
- 231100000397 ulcer Toxicity 0.000 title abstract 2
- 229940079593 drug Drugs 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 230000002496 gastric effect Effects 0.000 title 1
- 239000003102 growth factor Substances 0.000 title 1
- 241000124008 Mammalia Species 0.000 abstract 3
- 102000010780 Platelet-Derived Growth Factor Human genes 0.000 abstract 2
- 108010038512 Platelet-Derived Growth Factor Proteins 0.000 abstract 2
- 210000001035 gastrointestinal tract Anatomy 0.000 abstract 2
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1858—Platelet-derived growth factor [PDGF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US68508591A | 1991-04-12 | 1991-04-12 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE169226T1 true ATE169226T1 (de) | 1998-08-15 |
Family
ID=24750717
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT92917382T ATE169226T1 (de) | 1991-04-12 | 1992-04-10 | Verwendung von aus blutplättchen gewonnenem wachstumsfaktor zur herstellung eines medikaments zur behandlung von gastrointestinaler geschwüre |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP0584286B1 (de) |
| JP (1) | JPH06506939A (de) |
| AT (1) | ATE169226T1 (de) |
| AU (1) | AU657960B2 (de) |
| CA (1) | CA2108120C (de) |
| DE (1) | DE69226525T2 (de) |
| ES (1) | ES2123004T3 (de) |
| WO (1) | WO1992018153A1 (de) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5824297A (en) * | 1990-06-25 | 1998-10-20 | Oncogene Science, Inc. | Tissue-derived tumor growth inhibitors, methods of preparation and uses thereof |
| AUPN271295A0 (en) | 1995-05-02 | 1995-05-25 | Gropep Pty Ltd | Method of treatment |
| US5149691A (en) * | 1991-03-12 | 1992-09-22 | Creative Biomolecules, Inc. | Issue repair and regeneration through the use of platelet derived growth factor (pdgf) in combination with dexamethasone |
| US5817625A (en) * | 1992-09-21 | 1998-10-06 | Oncogene Science, Inc. | Methods of prevention of oral mucositis with transforming growth factor beta |
| GB9619660D0 (en) * | 1996-09-20 | 1996-11-06 | Scient Hospital Suppl Int Ltd | Prevention of gastrointestinal damage |
| KR100883999B1 (ko) * | 2004-05-18 | 2009-02-17 | 젠티엄 에스피에이 | 점막염 치료를 위한 설글리코타이드의 용도 |
| ITMI20040989A1 (it) | 2004-05-18 | 2004-08-18 | Gentium Spa | Uso del sulglicotide per iul trattamento delle mucositi |
| US20100233689A1 (en) | 2007-03-22 | 2010-09-16 | The General Hospital Corporation | Pyrazoloanthrone and derivatives thereof for the treatment of cancer expressing 'mullerian inhibiting substance' type ii receptor (misrii) and of excess androgen states |
| EP3941479A1 (de) * | 2019-03-20 | 2022-01-26 | Reponex Pharmaceuticals A/S | Zielgerichtete biologische mittel gegen schleimhautdefekte des magen-darm-traktes |
| CN114432342A (zh) * | 2020-11-06 | 2022-05-06 | 上海萨美细胞技术有限公司 | 无细胞脂肪提取液对溃疡性结肠炎的治疗用途 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4350687A (en) * | 1980-02-10 | 1982-09-21 | Research Corporation | Platelet derived cell growth factor |
| US4479896A (en) * | 1981-12-11 | 1984-10-30 | Antoniades Harry N | Method for extraction localization and direct recovery of platelet derived growth factor |
| DE3855504T2 (de) * | 1987-04-22 | 1997-01-23 | Chiron Corp | Rekombinante Herstellung von A-Ketten-Polypeptiden von PDGF |
| US4874746A (en) * | 1987-12-22 | 1989-10-17 | Institute Of Molecular Biology, Inc. | Wound headling composition of TGF-alpha and PDGF |
| AU613776B2 (en) * | 1987-12-22 | 1991-08-08 | Institute Of Molecular Biology, Inc. | Wound healing |
| US5175147A (en) * | 1988-08-19 | 1992-12-29 | Takeda Chemical Industries, Ltd | Acid-resistant fgf composition and method of treating ulcerating diseases of the gastrointestinal tract |
| CA2005600A1 (en) * | 1988-12-20 | 1990-06-20 | Cal-Henrik Heldin | Endothelial cell growth factor |
-
1992
- 1992-04-10 WO PCT/US1992/002941 patent/WO1992018153A1/en not_active Ceased
- 1992-04-10 CA CA002108120A patent/CA2108120C/en not_active Expired - Fee Related
- 1992-04-10 AT AT92917382T patent/ATE169226T1/de not_active IP Right Cessation
- 1992-04-10 EP EP92917382A patent/EP0584286B1/de not_active Expired - Lifetime
- 1992-04-10 DE DE69226525T patent/DE69226525T2/de not_active Expired - Fee Related
- 1992-04-10 JP JP4510274A patent/JPH06506939A/ja active Pending
- 1992-04-10 AU AU17959/92A patent/AU657960B2/en not_active Ceased
- 1992-04-10 ES ES92917382T patent/ES2123004T3/es not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| DE69226525D1 (de) | 1998-09-10 |
| ES2123004T3 (es) | 1999-01-01 |
| CA2108120C (en) | 1997-03-25 |
| DE69226525T2 (de) | 1999-04-08 |
| AU657960B2 (en) | 1995-03-30 |
| WO1992018153A1 (en) | 1992-10-29 |
| CA2108120A1 (en) | 1992-10-13 |
| EP0584286B1 (de) | 1998-08-05 |
| JPH06506939A (ja) | 1994-08-04 |
| AU1795992A (en) | 1992-11-17 |
| EP0584286A4 (en) | 1994-08-24 |
| EP0584286A1 (de) | 1994-03-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE133336T1 (de) | Verwendung von rapamycin zur herstellung eines arzneimittels zur behandlung von augenentzündungen | |
| DE69636085D1 (de) | Verwendung von gamma-Linolensäure oder Dihomogammalinolensäure zur Herstellung eines Medikaments zur Behandlung von Huntington's Chorea | |
| DE69523350D1 (de) | Behandlung von hyperproliferativen Gefässerkrankungen | |
| ATE201594T1 (de) | Verwendung von venlafaxin oder eines aryloxy- propanaminderivates zur herstellung eines medikaments zur behandlung von inkontinenz | |
| NZ222551A (en) | A method of healing wounds and a method of regenerating bone; pharmaceutical composition of platelet-derived growth factor and insulin-like growth factor | |
| PT646012E (pt) | Cura de feridas e tratamento de perturbacoes fibroticas por tgfbeta-3 | |
| ATE116550T1 (de) | Behandlung von neoplastischen krankenheiten mit interleukin-10. | |
| DE69232864D1 (de) | Verwendung von Ranitidin-Wismut-Zitrat in Kombination mit Claritromyzin oder Claritromyzin und Tetrazyklin zur Herstellung eines Arzneimittels zur Behandlung gastrointestinaler Beschwerden | |
| DK0479799T3 (da) | Sårheling | |
| DE69328635D1 (de) | Verwendung eines stoffgemisches enthaltend alpha hydroxy organische säure zur herstellung eines arzneimittels zur behandlung von kleinen mundgeschwüren | |
| DE69226525D1 (de) | Verwendung von aus blutplättchen gewonnenem wachstumsfaktor zur herstellung eines medikaments zur behandlung von gastrointestinaler geschwüre | |
| ATE137965T1 (de) | Verwendung von tomoxetine zur behandlung von funktionsstörungen der niedrigen harnwege | |
| DE68907679D1 (de) | Sauerwiderstehender fibroblast-wachstumsfaktor, zubereitung zur behandlung von magen-darmweg-geschwuerkrankheiten. | |
| ATE196738T1 (de) | Verwendung von immunglobulin-präparationen zur herstellung eines medikaments zur oralen verabreichung zur behandlung und prophylaxe chronischer schmerzzustände | |
| NO894222L (no) | Fremgangsmaater for behandling og profylakse av pneumocytis carinii pneumoni og andre sykdommer og forbindelser og formuleringer for anvendelse i nevnte metoder. | |
| RU93033683A (ru) | Способ лечения язвенной болезни двенадцатиперстной кишки | |
| DE69327314D1 (de) | Zusammensetzungen enthaltend Lipoprotein-Associated-Coagulation-Inhibitor (LACI) zur Herstellung eines Medikaments zur Behandlung von akuten oder chronischen Enzündungen | |
| DE69632677D1 (de) | Verwendung eines Rifamycin-Derivates zur Herstellung eines Medikamentes zur Behandlung von Krankheiten verursacht durch Helicobacter pylori-Infektionen | |
| DE69109314D1 (de) | Humaner monoklonaler Antikörper und diesen enthaltende Arzneimittelzusammensetzung zur Behandlung von Pseudomonasinfektionen. | |
| DE69511453D1 (de) | Verwendung einer Kombination von Antineoplastonen zur Herstellung eines Arzneimittels zur Behandlung der Neurofibromatose | |
| ATE31022T1 (de) | Verwendung von 4,5'-azo-bis-salicylsaeure zur herstellung eines arzneimittels zur behandlung entzuendlicher darmkrankheiten. | |
| DE3674213D1 (de) | Verfahren zur herstellung von keimabgetoeteten oder in ihrer virulenz abgeschwaechten substanzen sowie deren verwendung. | |
| DE69504392D1 (de) | Verwendung von Trovafloxacin oder dessen Derivaten zur Herstellung eines Arzneimittels zur Behandlung von H.Pylori Infektionen | |
| DE69307702D1 (de) | Verwendung von (e) - 2 - (p -fluorophenethyl)- 3 - fluoroallylamine zur behandlung der alzheimerschen krankheit | |
| DE59504374D1 (de) | Verwendung von Deoxyspergualin zur Herstellung eines Arzneimittels zur Behandlung von entzündlich-hyperreaktiven Erkrankungen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |